Skip to main content
. 2018 Oct 23;8:15658. doi: 10.1038/s41598-018-33927-5

Table 2.

Correlation between CD8+ TILs and tumor CD274/PD-L1 in stage II-III colon carcinoma patients (n = 864).

Parameters Total no. High tumor CD274/PD-L1 p value
OR 95% CI
All cases
    CD8+ TILs 864 <0.0001*
        Low 581 1
        High 283 2.073 1.554–2.766
MMR-proficient
    CD8+ TILs 794 <0.0001*
        Low 549 1
        High 245 1.904 1.404–2.582
MMR-deficient
    CD8+ TILs 68 0.0049*
        Low 30 1
        High 38 4.332 1.559–12.035

*p < 0.005 is significant.